Thursday, November 19, 2020: 9:20 AM
Pharmaceutical Discovery, Development and Manufacturing Forum (26) (vFairs Auditorium)
The novel coronavirus has brought significant change to our lives, and our workplaces. While some changes are temporary, the need to work remotely has significantly accelerated the adoption of new technology and business practices that will remain in place long after vaccines are available. Travel restrictions have forced tech-transfer teams to collaborate in new ways, requiring remote support of manufacturing suites, and democratizing decision-making through virtual teams. The need to work from home as put a spotlight on the importance of solid data-management infrastructure and enabled a culture change toward “default-to-open” data security practices. Crises serve to highlight the most critical work, and allow a fresh-eyed re-evaluation of organizational priorities. Change creates opportunity, and major change has created disruptive organizational innovation.
See more of this Session: PD2M Plenary Session Part 1, Expecting the Unexpected: Responses to Business Disruption in the Pharmaceutical Industry (Invited Talks)
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum